Podcasts about cancer care

Brian Kukan is a treasure. Not only is he doing powerful work to help those with cancer using his reiki, he is a musician and mathematician. I am glad to have him back on the show to demonstrate his skill in numerology.He reads the numerology for the AI model titans and we are left speechless.If cancer has ever impacted you and yours, please donate to the group below.And Brian Kukan does remote reiki sessions, selling gift certificates as well. Find him and all his links below.Brian Kukan's LinksLA Reiki Guy, Brian Kukan's websiteweSPARK orgDonate a reiki session to a cancer patient!Send us Fan MailSupport the showSupport Curious Cat, an independent, human-made podcast!Anxious about AI? Take two minutes to contact your local politician and ask them to tap the brakes on this technology. Still worried? Contact one of the orgs below and get involved. But for today, hug your kid, cook food and really breathe in deep as it simmers, walk in nature, brush a cat, donate to the food bank, brew a cup of tea, or draw a five-minute portrait of your dog. ***Is AI the Devil? on Substack!***Hero Organizations:80,000 HoursCenter for Humane TechnologiesState of Surveillance, an organization that helps foster online privacyBuy Curious Cat Podcast a Coffee!

In this episode, recorded live at ASCO Annual Meeting, host Shikha Jain, MD, speaks with W. Kimryn Rathmell, MD, PhD, about the new and evolving ways cancer care is delivered, building networks through advocacy and more. ·       Who is Dr. W. Kimryn Rathmell?  2:17 ·       Jain and Rathmell discuss the need for physician scientists in administrative leadership. 11:37 ·       How do you think networks and communities can impact careers? 17:08 ·       What are your thoughts on using social media in the cancer space? 22:35 ·       How do you think AI is going to transform the way we deliver care? 26:21 ·       As you have navigated your career, how have you approached challenges around being a woman in leadership roles? 29:29 We'd love to hear from you! Send your comments/questions to Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Jain on X: @ShikhaJainMD and on Instagram @shikhajainmd. Rathmell can be reached on LinkedIn. Jain reports no relevant financial disclosures. Rathmell reports a relationship with Interact Therapeutics, as well as institution relationships with Merck and Sitryx.

Send us Fan MailA cancer diagnosis can change everything in an instant. One conversation. Three words: "You have cancer." Suddenly, patients and families are faced with uncertainty, fear, and countless questions about what comes next.In this episode of MedStar Health DocTalk, host Debra Schindler sits down with medical oncologist and hematologist Dr. Ankit Madan of MedStar Southern Maryland Hospital Center, to discuss the critical first steps after a cancer diagnosis. Dr. Madan explains how patients move from diagnosis to treatment, how cancer is staged, and why building a multidisciplinary care team is essential for the best possible outcomes.The conversation explores the emotional impact of hearing a cancer diagnosis, the importance of patient navigators, social workers, nutritionists, mental health professionals, and the role patients play as active partners in their own care. Dr. Madan also discusses treatment advances, clinical trials, immunotherapy breakthroughs, second opinions, and practical advice for patients and families navigating one of life's most challenging journeys.Whether you or a loved one has recently been diagnosed with cancer, this episode offers guidance, reassurance, and expert insight into what happens after the diagnosis—and how patients can move forward with confidence and support.Topics covered:• Coping with the emotional impact of a cancer diagnosis• Understanding cancer staging and treatment planning• The role of biopsies, CT scans, PET scans, and additional testing• Building a multidisciplinary cancer care team• Patient navigators, social workers, and support services• Shared decision-making and patient autonomy• When to seek a second opinion• Clinical trials and emerging cancer treatments• Immunotherapy and advances in cancer care• Nutrition, exercise, and mental health during treatment• Cancer survivorship and ongoing surveillanceTo learn more about cancer care at MedStar Health, visit MedStarHealth.org/Cancer.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Developing a cancer drug is one of the most expensive, slow, and failure-prone processes in modern science. PharosAI is trying to change that – by building multimodal, AI-ready datasets from donated cancer tissue samples and making them available to researchers, biotech companies, and clinicians.In this episode, Technical Director Adrian La Porta speaks with PharosAI's Dr Lucie Burgess (COO) and Dr Emma Colliver (Research Fellow) about what it takes to curate cancer data at scale, why federated learning matters for patient privacy, where AI is already transforming diagnostics, and what synthetic patients could mean for clinical trials.Whether you work in life sciences, pharma manufacturing, digital health, or clinical data governance, understanding how AI is reshaping the drug discovery pipeline has direct implications for how and when new facilities will need to be built. This one is worth your time.Topics covered:00:00 Introduction00:01 What is PharosAI?00:06 Why AI can fundamentally change cancer care00:08 The venture behind the mission00:12 Lowering the barrier for UK biotech00:16 Are we at an inflection point?00:20 AI in diagnostics – what's already working00:24 Misconceptions about AI in biotech00:30 Data – acquiring, cleaning, and structuring00:34 Patient privacy, consent, and NHS data00:37 What cancer care could look like in 10 years00:40 Why this work matters personallySend us Fan MailTo learn more about Bryden Wood's Design to Value philosophy, visit www.brydenwood.com. You can also follow Bryden Wood on LinkedIn.

In this episode of Habari Live, Damon Ellison and Iesha Rowan examine the heartbreaking case of retired San Francisco firefighter Ken Jones, who died after his insurance provider denied coverage for a cancer treatment prescribed by his oncologist. Jones spent 17 years serving his community before being diagnosed with Stage 4 lung cancer, raising difficult questions about healthcare access, insurance companies, and whether life-saving treatment decisions should be determined by doctors or corporate policies.The conversation expands into the broader healthcare debate, including insurance denials, Medicare regulations, first responder cancer risks, and growing calls for healthcare reform in America.We also break down the biggest political clips and stories of the week:

A Place Called Hope: Dr. Francisco Contreras on Cancer Care, Faith, and Integrative Healing Episode Description In this episode of Conversations with a Chiropractor, Dr. Stephanie Wautier sits down with Dr. Francisco Contreras of Oasis of Hope in Tijuana, Mexico, for a thoughtful and deeply meaningful conversation about cancer care, hope, faith, prevention, and whole-person healing. Dr. Contreras shares the story of Oasis of Hope, founded by his father, Dr. Ernesto Contreras, more than 60 years ago. What began as a vision to care for the physical, emotional, and spiritual needs of cancer patients has grown into an international integrative oncology center serving patients from around the world. Stephanie and Dr. Contreras talk about the importance of treating the whole person, not just the diagnosis. Their conversation moves through integrative cancer care, immune support, natural and conventional treatment options, nutrition, exercise, stress, spiritual strength, early detection, breast cancer screening, biopsy concerns, and the role of hope in the healing process. Dr. Contreras also discusses why he believes patients need clear, understandable information when facing cancer. With so much information online, the process can feel overwhelming and frightening. His message is steady and compassionate: cancer is serious, but it does not have to immediately steal a person's joy, clarity, or hope. This episode includes discussion of cancer treatment, prevention, screening, integrative oncology, COVID vaccination concerns, and medical decision-making. It is meant to inform, encourage, and spark deeper questions, not replace personal medical advice. Anyone dealing with cancer, screening decisions, treatment options, supplements, or major health changes should work directly with a qualified medical team that understands their individual situation. In This Episode, Discover The story behind Oasis of Hope and its 60-year history How Dr. Ernesto Contreras helped shape a whole-person approach to cancer care Why Dr. Francisco Contreras believes emotional and spiritual support matter in healing What integrative oncology means at Oasis of Hope Why some natural therapies are studied but not widely approved or adopted How immunotherapy and immune support fit into the Oasis of Hope approach Dr. Contreras' perspective on rising cancer rates in younger people Simple lifestyle steps that may help reduce cancer risk The importance of fruits, vegetables, movement, stress reduction, and spiritual strength Why cancer symptoms often appear after disease is already present Mammograms, ultrasound, MRI, thermography, and early detection How Dr. Contreras thinks about biopsy risk versus diagnostic benefit When someone might consider contacting Oasis of Hope Why clear information matters when patients are overwhelmed The role of hope, mindset, faith, and joy during a cancer journey Stay Connected & Explore Learn More About Dr. Francisco Contreras and Oasis of Hope: Oasis of Hope: https://www.oasisofhope.com/ Dr. Francisco Contreras: https://www.oasisofhope.com/doctor/dr-francisco-contreras/ Request a Free Consultation: https://www.oasisofhope.com/contact-us/ Download Dr. Contreras' Free Cancer E-Book, The Art & Science of Undermining Cancer: https://www.oasisofhope.com/ Episode Sponsor: Learn more about Lemongrove Oil: https://www.lemongroveoil.com/ Connect with Conversations with a Chiropractor: Follow Us on YouTube: http://www.youtube.com/@ConversationswithaChiro Follow Dr. Stephanie on Facebook: https://www.facebook.com/wautierwellness Email for show-related inquiries and sponsorships: drstephaniewautier@yahoo.com Want to be a guest on Conversations with a Chiropractor? Send Stephanie Wautier a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/drstephanie Credits Podcast production by Brand|Sound. Start your podcast journey by emailing brandsoundpodcasts@gmail.com. Chapters 00:00 Introduction to Conversations with a Chiropractor 04:03 Meet Dr. Francisco Contreras 04:21 The Story Behind Oasis of Hope 08:08 Cancer Care Statistics and a Different Approach 08:46 Integrative Oncology and Treatment Options 10:47 Natural Therapies, Research, and FDA Approval 11:38 Immunotherapy and the Immune System 12:45 Science, Natural Therapies, and Patient Care 15:20 Rising Cancer Rates in Younger People 17:56 COVID Vaccination Questions and Cancer Concerns 21:20 Early Warning Signs and Cancer Prevention 22:23 Fruits, Vegetables, Exercise, and Risk Reduction 24:27 Stress, Immunity, and Spiritual Strength 26:05 Keeping Wellness Simple and Sustainable 29:36 Breast Cancer Screening, Mammograms, and Thermography 33:07 Biopsy Concerns, Risk, and Diagnostic Benefit 36:19 When to Contact Oasis of Hope 38:47 Referrals, Free Consultations, and Becoming a Patient 39:32 Dr. Contreras' Books and Free Cancer E-Book 42:10 Cancer Is Not Necessarily a Death Sentence 43:37 Hope, Mindset, and the Power of Joy 45:22 Final Thoughts and Closing

Cancer is increasingly recognized as a major global health challenge, yet for people living through war, displacement, and humanitarian crises, access to even basic oncology services can be difficult or impossible. While emergency responses typically focus on trauma care, infectious diseases, and immediate survival needs, cancer care remains largely absent from many humanitarian health programs. A review paper on this topic was published in Volume 17 of Oncotarget titled “Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings.” The study was led by first and corresponding author Pragnesh Parmar, with Gunvanti Rathod as co-author, both from AIIMS Bibinagar, Telangana, India. Full blog - https://www.oncotarget.org/2026/06/03/cancer-care-often-overlooked-in-humanitarian-crises/ Paper DOI - https://doi.org/10.18632/oncotarget.28856 Correspondence to - Pragnesh Parmar - drprag@gmail.com; (ORCID: orcid.org/0000-0002-8402-8435) Abstract video - https://www.youtube.com/watch?v=zXlhIBZyJ6Q Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28856 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, cancer care, humanitarian crisis, tele-oncology, global health policy, oncology triage To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

“I mean, I believe so strongly that food, what we eat, matters.” —Jen NolanIn this episode of the Real Health Podcast, Dr. Michelle Niesley is joind by Jen Nolan, owner of Remission Nutrition and nutrition advisor at Riordan Clinic, to explore nutrition recomendations and the differences between what is recommended during active treatment and after treatment.

In this episode, Leigh Ann welcomes Diana Salcido to share her deeply personal story of being diagnosed with stage 3C colon cancer after nearly a year of symptoms, medical dismissal, panic, abdominal pain, and an inner knowing that something was wrong. Diana walks listeners through the frightening path to diagnosis, including ER visits, being told she was simply anxious or constipated, an eventual bowel obstruction, emergency surgery, and the discovery that the cancer had spread to four lymph nodes. She also shares the complications that followed, including a leak, a second emergency surgery, an ileostomy, severe weight loss, pleural effusion, abscesses, additional surgery, and the loneliness of healing from injuries and trauma that others could not always see. Diana and Leigh Ann discuss the emotional toll of cancer, the difficulty of making treatment decisions amid conflicting medical opinions, and Diana's choice to pursue an integrative path guided by body intuition, discernment, and personalized support. The conversation explores the physical, emotional, and spiritual layers of healing, including trauma work, faith, rest, sunlight, diet changes, supplements, acupuncture, frequency therapies, and learning when to pivot based on what the body is communicating.Product Discount Codes + LinksHoolest: Website (Discount Code: THEACCRESCENT10)Froya Hair Care: Website (Link gives 10% off)Herbal Face Food: Website (Discount Code: LAL30)The Fullest: Website (discount code: LEIGH15)Episode LinksDiana's GoFundMeRelated EpisodesEp. 228: Dr. Lori Bouchard - The Missing Pieces in Cancer Care, Metabolism, Trauma, and Whole-Person HealingEp. 176: Leigh Ann Lindsey - How I Work with Cancer Patients to Address Emotional Root Causes to DiseaseWork w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

Message us!In this episode of Whitley Penn Talks, host Emily Landry is joined by Dr. Paul Bowman, longtime pediatric oncologist and co-chair of Leukemia Texas, who shares clear and hopeful insights on what leukemia is and how far treatment for the disease has come. Alongside him, Ashley Oviedo opens up about her daughter, Perry's, diagnosis, offering an honest and emotional look at the fear, uncertainty, and strength that define a family's journey through cancer.Together, they highlight the critical role organizations like Leukemia Texas play in supporting families medically, financially, and emotionally through their most challenging times. From the first signs of illness to the importance of accepting help and holding onto hope, this conversation is a reminder that no one should fight cancer alone.Fill out this form to have new episodes sent right to your inbox! Follow Whitley Penn on LinkedIn, Instagram, Facebook, and X for more industry insights and thought leadership!

The ACCC Global eXchange series is committed to highlighting cross-regional collaborations that advance cancer care delivery and workforce development nationwide. In this episode of CANCER BUZZ, Dr. Michael Cavnar discusses his humanitarian efforts in Zambia and why volunteering in this capacity is crucial and meaningful for US oncology providers. "The more you're around people that are different than you, the more different perspectives you see. It creates a more open mind and a better world, because people understand each other better." – Michael Cavnar, MD   Guest: Michael Cavnar, MD GI Surgical Oncologist UK HealthCare/Markey Cancer Center Lexington, KY Resources: Shared Solutions for Rural Oncology: Insights Across the Americas Breast Cancer Knowledge Gaps and Misconceptions Among Non-Medical Female University Students in Southwestern Nigeria A Global Perspective: Innovative Care and Supporting Women in Medicine in Nigeria #ACCCNOC: Advancing Global Health Equity  

Cancer care is evolving, and today's conversation with Martha Tettenborn dives into one of the most overlooked aspects of healing and prevention: metabolic health. Martha is a cancer survivor, author of Hacking Chemo, and currently works with Dietary Therapies, where she helps support patients using evidence-based nutritional and metabolic approaches alongside conventional cancer care. In this follow-up conversation, we move beyond Martha's personal story and explore what she's seeing firsthand in patients today. We discuss the growing connection between insulin resistance, blood sugar dysregulation, inflammation, and cancer progression — and why metabolic health deserves a much bigger place in the cancer conversation. Martha also shares practical insights into keto therapies, fasting during treatment, common mistakes patients make when trying these approaches on their own, and the importance of individualized care and professional guidance. This episode is not only valuable for those navigating cancer, but also for anyone struggling with fatigue, inflammation, insulin resistance, stubborn weight gain, or chronic metabolic dysfunction. So many of the foundational principles that support metabolic healing apply broadly to overall health and disease prevention. ✨ How Martha's perspective has evolved from cancer survivor to working directly with patients at Dietary Therapies ✨ Common metabolic patterns she is seeing in cancer patients today ✨ The connection between insulin resistance, blood sugar dysregulation, and cancer progression ✨ What people are misunderstanding about keto and fasting for cancer care ✨ Who may not be a good candidate for fasting during treatment ✨ The biggest mistakes people make when trying dietary therapies on their own ✨ How metabolic therapies can work alongside conventional oncology care ✨ Why nutrition and metabolic health are still often overlooked in cancer treatment ✨ Lifestyle habits and strategies that may support long-term healing and recurrence prevention ✨ Why metabolic health matters even for those who have never faced a cancer diagnosis LINKS & RESOURCES: Learn more about Martha's work through Dietary Therapies Get Martha's book Hacking Chemo READY TO IMPROVE YOUR METABOLIC HEALTH? ✨ My 90-Day COMPASS Reset begins Monday, June 1st! This guided reset is designed to help you stabilize blood sugar, improve energy, reduce inflammation, and begin healing your metabolism with sustainable strategies focused on meal timing, metabolic flexibility, circadian health, and nervous system support. The only requirement to join is being on the Feel Great System. Get started here: https://ufeelgreat.com/c/SHANAH

In recognition of National Women's Health Month, this episode of Thinking Thoracic analyzes the evolving landscape of female-specific lung cancer care. Co-hosts Dr. Erin Gillaspie and Dr. Jane Yanagawa sit down with guest Dr. Leah Backhus to discuss a critical disparity: lung cancer is the leading cause of cancer death among women, yet screening practices remain inequitable.    This timely episode moves beyond smoking history to examine the rise of lung cancer in never-smokers and Asian women. From the "stigma" of a diagnosis to innovative solutions like co-scheduling screenings with mammograms, providing a powerful call to action for more inclusive, biomarker-driven care. 

Host: Mindy McCulley, MS, Extension Specialist for Instructional Support, Family and Consumer Sciences Extension, University of Kentucky  Guest: Dr Ayman Qasrawi, Assistant Professor of Medicine, (Hematology) and Dr. Ruta Arays, Assistant Professor of Medicine (Medical Oncology), Markey Cancer Center Cancer Conversations Episode 75 Host Mindy McCulley interviews Dr. Ayman Qasrawi (Dr. Q) and Dr. Rita Arays of the UK Markey Cancer Center about multiple‑modality management and interdisciplinary collaboration in treating advanced melanoma. The episode explains tumor‑infiltrating lymphocyte (TIL) and why this personalized immunotherapy can produce durable responses when other options fail. Key takeaways include the multidisciplinary workflow needed to deliver TILs in Kentucky, candidate selection and timing/referral considerations, program availability at UK (and UofL), and implications for future vaccine research and community care.   Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On Twitter @UKMarkey

In this episode of the PQI Podcast, we are joined by Chadi Nabhan, MD, MBA, FACP, nationally recognized oncology leader, physician-executive, author, and host of the Healthcare Unfiltered podcast. Dr. Nabhan discusses his career journey across academic medicine, clinical oncology, healthcare leadership, precision medicine, and artificial intelligence innovation. The conversation explores how AI is beginning to reshape oncology research and cancer care, including opportunities to improve clinical trial operations, optimize protocols, enhance site selection, support real-world evidence generation, and ultimately accelerate patient access to novel therapies. The episode also highlights the growing importance of data quality, traceability, and diversity within AI-driven healthcare models. Dr. Nabhan shares perspectives on balancing innovation with human oversight, addressing skepticism surrounding AI adoption, and ensuring technology remains focused on improving patient care while supporting physicians, pharmacists, nurses, and the broader oncology care team. In addition to discussing the future of AI in oncology, Dr. Nabhan reflects on his experiences as an author and storyteller, including his books Toxic Exposure and The Cancer Journey, as well as his upcoming book, AI and Cancer Care: When Machines Meet Modern Medicine. The conversation also explores his growing interest in fiction writing and the creative process behind developing characters and medical storylines.

Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

Cancer screening access is improving. But what happens after screening? In this episode of the miniVHAN podcast, Shari Rajoo, MD, chief medical officer of Ballad Health, shares insights on patient-centered care, health system gaps and the growth of accessible screening options. She also advocates for community health navigators and health coaches to better support patients through every phase of their care.  

In a special edition of the This Week in Global Development podcast, Devex cofounder and Executive Vice President Alan Robbins sits down with Brazilian thoracic surgeon Dr. Ricardo Sales do Santos to discuss a revolutionary approach to tackling lung cancer in medically underserved communities in Brazil.   As the most lethal form of cancer globally, lung cancer often goes undetected until its final stages, but Dr. Santos and the Bristol Myers Squibb Foundation (are working to change that narrative through a combination of mobile technology and local capacity building. By bringing advanced CT scanning units directly into high-risk, low-income communities, they are catching tumors when they are small and potentially curable, fundamentally shifting the odds for thousands of patients.   The conversation also touches on the logistical and cultural hurdles of delivering specialized oncology care to remote areas. Dr. Santos highlights the importance of “bringing the clinic to the patient,” utilizing mobile CT units and telemedicine to bridge the gap in healthcare access. Beyond the technology, the success of the program relies heavily on empowering local health workers and community members to recognize early cancer warning signs and overcome the stigma associated with a cancer diagnosis. This approach not only improves individual health outcomes but also strengthens the broader healthcare system, offering a scalable model for global health initiatives.   To learn more about sustainable improvements in cancer care and get a compelling look at how local solutions can drive global change, listen to this special edition of This Week in Global Development. For more international development news, visit: http://www.devex.com Visit  Strengthening Care Systems — a series raising awareness of the scale of the global lung cancer burden and the systems-level changes required to address it: https://pages.devex.com/strengtheningcaresystems.html

Leigh Ann welcomes Sara Banta, founder of Accelerated Health Products, for a conversation on detoxification, cellular energy, and the body's innate capacity to heal. Sara shares her personal health journey, including her own struggles with gut issues, heavy metals, hair loss, and depletion, as well as her children's health challenges that led her deeper into functional healing. The conversation explores the role of iodine, copper, silver, amino acids, liver support, and detox pathways in supporting thyroid health, immune function, cellular repair, and energy. Sara also explains how environmental toxins, radiation, processed foods, stress, and disrupted detox pathways can contribute to fatigue, weight gain, hormone issues, histamine reactions, and chronic illness. Leigh Ann and Sara discuss practical support for people navigating cancer, chronic illness, scans, contrast dye, radiation exposure, and the everyday toxic burden of modern life. Product Discount Codes + LinksFroya Organics: Website (Link gives 10% off)MitaCell: Website (Use code LEIGHANN for 10% off)Vio2: Website (Use code LEIGHANN for 10% off)Guest InfoAccelerated Health Products - WebsiteAccelerated Health Products- InstagramRelated EpisodesEp. 235: Dr. Neil Nathan - Three Reasons Why the “Sensitive” Patient Isn't Healing and Where to BeginEp. 228: Dr. Lori Bouchard - The Missing Pieces in Cancer Care, Metabolism, Trauma, and Whole-Person HealingWork w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

Can cancer care be delivered virtually without compromising quality? In this episode of The Lebanese Physicians Podcast, I speak with Dr. Dany Matar about Color, the first ASCO-certified virtual cancer clinic in the United States. We discuss how artificial intelligence, multidisciplinary expert review, and virtual oncology are improving access to world-class cancer care, shortening time to diagnosis and treatment, and reducing costs for patients, employers, and health plans. Dr. Matar also shares his inspiring journey from medical school in Lebanon to public health, consulting, and healthcare innovation in the U.S. #CancerCare #ArtificialIntelligence #Oncology #VirtualCare #DigitalHealth #HealthcareInnovation #PrecisionMedicine #Telemedicine #ASCO #ColorHealth #LebanesePhysiciansPodcast #CancerScreening #MedicalInnovation #HealthcareAI #subscribe  @thelebanesephysicianspodcast  On all podcast apps Website: https://thelebanesephysicianspodcast.podbean.com

#Podcast #MentalHealth #MedicalClowning #Healing #LaughterTherapy #Sheetal #CancerCare #MentalWellness #Healthcare #EmotionalHealing #ArmyLife #SelfLove #HumanConnection #TheMohuaShowWhat does it take to leave a stable academic career and become a medical clown?In this powerful episode of The Mohua Show, host Mohua Chinappa sits down with Sheetal Agarwal — Delhi-based sociologist, TEDx speaker, and founder of Clownselors, India's pioneering non-profit using medical clowning to heal patients in hospitals, old age homes, shelters, and beyond.Once a lecturer at Amity and IP University, Sheetal made a bold pivot in 2016 — trading classrooms for hospital corridors, armed with a red nose and radical empathy. Since then, Clownselors has touched hundreds of thousands of lives across India, bringing laughter to cancer patients, the elderly, soldiers, special schools, and even corporate environments.Her philosophy is simple yet profound: “Treat the human before the condition.”

Dr. Robert Soiffer took an interest in medicine at an early age when he played a physician in his first-grade play.  Today, he is a leading physician, researcher, and teacher at Dana-Farber Cancer Institute, a world leader in oncology.  In this episode, Dr. Soiffer describes the incredible pace of change in the field of cancer research and treatment and the detection tools and cures that are right around the corner.  He also reflects on how he maintains a positive and optimistic outlook despite the many times he's forced to deliver terrible news to patients and families.  While he tries hard not to bring these tough times home with him, he also stresses the importance of keeping his humanity and treating his patients and their families as people, not just statistics.     Chapters:  02:29 Dana-Farber's Special Mission  Dr. Soiffer discusses what makes Dana-Farber Cancer Institute unique, emphasizing its focus on cancer patients and the common purpose among all staff.   05:50 Evolution of Cancer Treatment  This segment details the seismic shift in cancer treatment over the past 40 years, from nonspecific chemotherapy to targeted therapies focusing on specific mutations.   10:25 Bone Marrow Transplants and Graft vs. Leukemia  Dr. Soiffer delves into the history of bone marrow transplants, highlighting the Nobel Prize-winning work of E. Donald Thomas and the intriguing concept of graft versus leukemia effect.   15:02 The Role of Medical Education and Mentoring  This chapter emphasizes the critical role of medical education and mentoring in shaping the future of medicine, drawing from Dr. Soiffer's experience as chief medical resident and mentor. He discusses the mutual learning process between experienced physicians and younger generations, and the importance of continuous learning.  19:50 Personal Impact of Oncology Work  Dr. Soiffer reflects on the emotional challenges of his work, balancing optimism with realism and honesty while treating patients facing life-threatening situations. He discusses the difficulty of compartmentalizing emotions and the importance of maintaining humanity and connection with patients and their families, even when outcomes are not positive.  24:57 The Value of Clinical Trials  This chapter explains the critical role of clinical trials in advancing cancer treatment, from early-stage phase I trials to comparative studies. Dr. Soiffer describes patients participating in these trials as brave pioneers, highlighting how targeted, immune, and cellular therapies would not exist without their contributions.  28:39 Global Collaboration in Medicine  Dr. Soiffer discusses the extensive global collaboration in medical and scientific fields, emphasizing the shared mission to develop therapies for suffering patients.   35:33 Future of Cancer Treatment and Prevention  Looking ahead, Dr. Soiffer predicts less toxic and more precise cancer treatments with improved therapeutic ratios, focusing on overcoming resistance and early detection. He discusses the potential of preventing progression to full-blown malignancy through early intervention and the growing understanding of germline predispositions to cancer.  41:26 Conclusion and Call to Optimism  The episode concludes with Bill Burke thanking Dr. Soiffer for his time and invaluable insights, highlighting the rapid pace of change and innovation in cancer research. He also expresses hope and optimism for the future of cancer care. 

Welcome to OncLive On Air®! I'm your host today, Riley Kandel.OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.During Esophageal Cancer Awareness Month, OncLive® sat down with Peter Enzinger, MD, to discuss evolving standards and ongoing areas of uncertainty in the diagnosis and management of esophageal cancer. In the exclusive interview, Enzinger highlighted common diagnostic and staging pitfalls in newly diagnosed disease; outlined the evolving role of surgery, chemoradiation, and multidisciplinary care; and reviewed emerging targeted therapeutic strategies shaping treatment decisions in esophageal and gastroesophageal cancers. He also discussed ongoing clinical trials of interest, including studies evaluating zanidatamab-hrii (Ziihera), pembrolizumab (Keytruda)–based nonoperative approaches, and novel combinations incorporating Claudin 18.2–targeted therapy.Enzinger serves as director of the Center for Esophageal and Gastric Cancer, institute physician, and medical oncologist at Dana-Farber Cancer Institute, as well as an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. _____That's all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field.For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.If you liked today's episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!Thanks again for listening to OncLive On Air.*OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Christine Fader joins Anita and Mel from Canada to talk about the death of her husband, Michael, and the reality of living through not one but two cancer diagnoses. In 2018, Michael was diagnosed with the “good” kind of throat cancer. In 2020, he was diagnosed with a completely new and far more aggressive lung cancer. By November 2022, he was gone.Michael's terminal cancer was both aggressive and underfunded despite lung cancer being one of the most commonly diagnosed cancers there is. He held onto hope for new treatments as long as he could.The episode also digs into the trauma that can exist underneath cancer care. Christine shares how Michael's childhood trauma and later medical trauma shaped his experience as a patient, and why she is now advocating for trauma-informed cancer care and better education for doctors. With a background in speaking, teaching, and advocacy, she's working to push conversations about cancer beyond survival rates and treatment plans to include the emotional and psychological realities patients and caregivers live through.Find Christine at https://www.christinefader.comSponsored by:BetterHelp.com. Save 10% off the first month of online therapy done securely, online with our unique link: https://trybetterhelp.com/wwdnMint Mobile: Mobile phone plans with great service and coverage starting at $15/month https://trymintmobile.com/wwdnJoin our Patreon for ad-free episodes and more!http://www.patreon.com/wwdnNeed some Snarky Grief merch?http://shop.widowwedonow.comWanna buy us tacos?http://www.buymeacoffee.com/widowwedonowFollow our YouTube channelhttps://www.youtube.com/@widowwedonow Support the show

Why is brain cancer so hard to detect and treat - and what if we could change that? In this episode of Rx for Biotech, host Chris Leidli sits down with Marc Hedrick, CEO of Plus Therapeutics, and Russell Bradley, General Manager of CNSide Diagnostics, to explore a new, integrated approach to treating some of the most challenging cancers in medicine: central nervous system (CNS) cancers, including glioblastoma and leptomeningeal metastases. Brain and CNS cancers are among the most difficult to treat because of the blood-brain barrier, which prevents most drugs from reaching tumors. In fact, only a small percentage of therapies can effectively cross into the brain—limiting treatment options and outcomes. Plus Therapeutics is tackling this problem with a novel approach using targeted radiation therapy delivered directly to tumors, bypassing the blood-brain barrier. Their lead program uses a radioactive isotope (rhenium-186) delivered via nanoliposomes, allowing high doses of radiation to reach the tumor while minimizing damage to the rest of the body. At the same time, CNSide Diagnostics is helping physicians detect cancer earlier and monitor treatment response using an advanced cerebrospinal fluid (CSF) diagnostic test. This highly sensitive test can identify even small numbers of tumor cells—helping doctors make faster, more informed treatment decisions. Together, this combination of diagnostics + therapeutics + data represents a new model for precision oncology and personalized cancer care. In this episode, we discuss: • Why brain cancer is so difficult to treat • The role of the blood-brain barrier in limiting therapies • How targeted radiation therapy can improve outcomes • The importance of early detection and diagnostics • How monitoring tumor cells can guide treatment decisions • The future of integrated cancer care (theranostics) This conversation offers a powerful look at how innovation in both treatment and diagnostics could help improve survival and quality of life for patients with some of the most aggressive cancers.

In this week's episode, "Cancer Care in Transition: Precision Medicine, Immunotherapy, and Patient Choice," we look at how cancer treatment is changing at the exact moment when patients are trying to move from crisis mode into something like a new normal. Precision medicine now uses a person's genes, tumor markers, and even lifestyle to match them with targeted drugs or immunotherapies instead of one‑size‑fits‑all chemo, while immuno‑oncology has created a growing group of survivors living with long‑term effects and unique follow‑up needs. At the same time, shared decision‑making has become essential: patients are being asked to weigh complex options with different risks, benefits, costs, and impacts on quality of life—and their preferences, values, and tolerance for uncertainty can dramatically shape which path is "right" for them. We'll talk about what this transition looks like in real life, how precision tools and immunotherapy are reshaping survivorship, and how patients and caregivers can find their voice when the choices are anything but simple.

A young man from Galway, who plays his rugby with Galway Bay Rugby Club, has organised a fundraiser in memory of his Aunt who passed away last June after a very brave battle with leukaemia. Over the past three yearsm, Elin Mulhall has been growing his hair with the goal of donating it and on Tuesday next, he will be getting it cut and donating it to the Rapunzel Foundation, where it will be used to make a wig for someone in need. He is also fundraising for Cancer Care West and Leukaemia Trust. The original target was around €1,000, but the response has been incredible — the total has now exceeded €8,500, which has come as a real shock to the family. Elin, came into studio on Sunday and spoke to John on Sunday Sport.  You can donate by going to https://www.idonate.ie/fundraiser/elinmulhall or by scanning the QR code below

What does prevention really look like when cancer risk is part of your life? In this episode of The SEAM Podcast, Amy Cohen Epstein sits down with Dr. Mona Guo, gynecologic oncologist at USC Keck and part of the Lynne Cohen Foundation Preventive Care Clinic, for a conversation on risk-reducing surgery, ovarian cancer treatment, and the deeply personal decisions women face in navigating care. Drawing on her work with women at increased risk for breast and ovarian cancers, Dr. Guo offers a clear-eyed perspective on fallopian tube removal, hormonal prevention strategies, menopause, self-advocacy, and quality of life during and after treatment.For more, follow The Seam on Instagram, watch full episodes on Youtube, or visit the Lynne Cohen Foundation website.Produced by Peoples Media Hosted on Acast. See acast.com/privacy for more information.

Wildfires, storms, and floods can lead to missed appointments and hospital closures – with life-and-death consequences. Learn more at https://www.yaleclimateconnections.org/ 

When someone is diagnosed with cancer, the expectation is that care begins quickly and smoothly. In reality, many patients and caregivers find themselves navigating a complicated system, juggling access barriers, approvals, and logistics before treatment even begins.In this episode of Patient Advocacy Voices, host Eric Racine is joined by Meagan O'Neill, Executive Director of the Association of Cancer Care Centers (ACCC), alongside co-host Rachel Solomon of Sanofi. Together, they explore how cancer care is shaped not just by scientific advances, but by the systems, operations, and local realities that determine whether patients can access timely, effective care.Drawing on her background in oncology consulting and her personal experience as a caregiver for her mother, Meagan shares why so many of the biggest challenges in cancer care are structural rather than scientific. The conversation dives into the crucial role of community oncology, the operational gaps that delay access to care, and how ACCC is working to bridge the gaps between innovation and practical, everyday solutions for both providers and patients. With most cancer care delivered in community settings, advocacy leaders will learn about ACCC's “how to” approach that helps close the gap between breakthrough science and real patient access.In this episode, you'll gain insights on:Why access to care is often determined by where a patient livesNon-clinical barriers to patient outcomes, including fragmented systems, administrative burden, and workforce shortagesThe critical role community care settings play in delivering the majority of care in the U.S.How collaboration across clinical centers, care teams, and advocacy organizations can reduce friction for patients and providers alikeHow data and patient stories together can drive more effective advocacy and system changeThis episode is a timely reminder that improving patient care requires more than medical innovation alone. It takes practical solutions, stronger collaboration, and systems designed to help patients move through care with fewer delays and less burden. It also reveals how patient advocacy organizations can play a critical role in making this happen.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Send us Fan MailOn this episode of the Stories to Create Podcast, Cornell Bunting sits down with Dr. Zanetta Lamar, a distinguished, board-certified specialist in oncology and hematology who is making a powerful impact in the lives of patients in Naples.With over 15 years of experience in medicine, Dr. Lamar began her journey at Meharry Medical College, followed by advanced training at Wake Forest Baptist Health, where she completed both her residency and fellowship in hematology-oncology. A proud Louisiana native, her passion for medicine was evident from an early age—often found as a child immersed in medical encyclopedias, already envisioning her future as a physician.Dr. Lamar's career began in academic medicine as a clinician, researcher, and educator. However, her desire to create a deeper, more personal impact led her to transition into community-based care, where she now works closely with patients navigating some of the most challenging moments of their lives. She considers it both a responsibility and a privilege to guide individuals through their cancer journey with compassion, expertise, and unwavering support.Beyond her clinical work, Dr. Lamar is a dedicated contributor to the advancement of medicine. She has authored over 20 scientific publications, participated as a principal and co-investigator in multiple cancer-related clinical trials, and remains an active member of leading professional organizations including the American Society of Hematology and the American Society of Clinical Oncology.In this episode, we explore not only her professional journey, but the heart behind her calling—what it truly means to serve, to lead with empathy, and to walk alongside others in their most critical moments. Support the showThank you for tuning in with EHAS CLUB - Stories to Create Podcast

“Driving all the way to Nashville for four hours can really get strenuous,” said Joel Edwards, a U.S. Army Infantry Veteran receiving oncology care at the Pointe Centre VA Clinic in Chattanooga, Tennessee. According to the Department of Veterans Affairs (VA), nearly one-quarter of Veterans live in rural areas, where specialty care often requires extended travel. For years, that was the reality for many Veterans living in southeast Tennessee and northern Georgia who experienced long drives for cancer treatment, often repeated week after week. Now, that routine is changing. VA Tennessee Valley Healthcare System (TVHS) designated the Pointe Centre VA Clinic in Chattanooga as a VA Close to Me cancer care site, becoming one of more than 30 VA medical centers nationwide to be selected for the expansion, bringing oncology services closer to where Veterans live while maintaining coordinated care within VA's health care system. Veterans face a higher risk of developing certain cancers due to exposures during military service, including Agent Orange and burn pits, which VA recognizes as linked to multiple presumptive cancers under the PACT Act. For many Veterans, that increased risk makes access to timely, coordinated care even more critical. “Close to Me is designed to bring access to the Veterans in some of the smaller communities outside of Nashville and Murfreesboro where oncology services have traditionally been offered for Veterans,” said Whitney Worthy, a nurse practitioner at the clinic. Prior to this expansion of care, Veterans in the Chattanooga region traveled up to three hours to the Nashville VA Medical Center or were referred to a community provider. “It can be a lot on the Veteran to travel up to 60 minutes or more to an appointment once a week, or sometimes even twice a week,” said Kim Hughes, a registered nurse at the clinic. “What we are hoping to do is allow them to spend less time on the road and more time with their families, resting and recovering.” For more than a year, Edwards made the long drives for treatment, always accompanied by his wife, Sandra Edwards. “He used to have two or three appointments every week after the initial cancer surgery,” Sandra recalled. “It's nice now not having to drive all over the place to get to his appointments.” Since treating its first patient in December 2025, the clinic has already served more than 60 Veterans, saving over 25,000 miles in travel and significantly reducing the burden on Veterans and their families. By expanding specialty care and transitioning care back into VA, the program has also resulted in more than $50,000 in cost avoidance, allowing those resources to be further invested into Veteran care. “Veterans in this area want to stay within the VA system,” said Worthy. “As far as continuity of care, having all your providers under one system is a big deal.” Coordinating care across multiple providers and systems can be complex, particularly for patients undergoing frequent or specialized treatment. By keeping care within VA, providers can maintain greater continuity, ensuring Veterans receive consistent, connected care throughout their treatments. Edwards said the difference has been noticeable, not just in traveling distance, but in how he feels day by day. “Getting the infusion here has been no problem,” Edwards said. “I feel better and I don't drag out of bed.” Veterans navigating cancer treatment are often not doing it alone. Caregivers and spouses like Sandra play a critical role in managing appointments, providing transportation, and offering support throughout each stage of care. “I don't want something to happen to him where he can't drive home after his treatment,” Sandra said. “I don't take that change, so I come with him every time” Inside the clinic, the treatment experience is designed with both patients and caregivers in mind. The clinic offers a smaller, more personalized setting. Infusion chairs offer heat and massage features, caregivers are encouraged to remain close by with their own comfortable seating, and appointments are coordinated to reduce time spent waiting and traveling. Together, those features help support both comfort and connection. Sandra said staff walk both patients and caregivers through each step of the process. “They will explain every step of the process with you just like they do to the patient getting treatment,” Sandra reassured. Referring to the availability of care at the Pointe Centre VA Clinic, Edwards said, “I'm glad you're here. I've always got good care at the VA.” Veterans receiving care through VA TVHS can speak with their provider about whether the Close to Me program at the Pointe Centre VA Clinic is right for them.

Join Dr. Amoon Jamzad (Computing) for a discussion of his research at the intersection of artificial intelligence and cancer care with a foucs on his open-source MassVision software.

Send us Fan MailIf you or someone you love just received a cancer diagnosis, what are the first three things you need to know?In this clip from our episode “Can AI Help Us Finally Beat Cancer”, host John Driscoll and guest Dr. Sanjay Juneja, TheOncDoc, walk through the essential steps every cancer patient should take immediately after diagnosis.Listen to the full episode here

I sit down with a global health advocate, author, Winning The War On Cancer, and the leader in integrative cancer research, Sylvie Beljanski explore a different side of the cancer conversation. With over two decades of experience—from international summits to global awareness campaigns—her mission has been to make holistic, science-backed solutions more accessible and better understood.Together, we discussed what integrative cancer care really means, the role of plant-based and non-toxic research, and how patients can become more informed and empowered in their health journey.This episode is not about replacing traditional medicine—it's about expanding the conversation, asking better questions, and understanding the full picture of care. Addl. information: https://www.winningthewaroncancer.com/

This episode of LCC covers the work of our nursing and allied health professional committee and, most importantly, highlight their role in the care of patients with thoracic malignancies. Guests: Professor Nicole Kiss is a Fellow of Dietitians Australia and Clinical Associate Professor in the Institute for Physical Activity and Nutrition at Deakin University. Nicole co-leads the Exercise and Nutrition for Cancer research group, with her research focused on early identification of cancer-related muscle loss and improving access to treatment. Dr. Morten Quist is a former IASLC Board member and is currently an Associate Professor and Research Physiotherapist at the University Hospital of Copenhagen, Rigshospitalet. For the past 25 years, he has pioneered clinical exercise-based rehabilitation for people living with cancer, with a primary focus on exercise, prehabilitation, and rehabilitation in lung cancer. His work bridges research, clinical care, patient advocacy, and voluntary engagement – always with patient wellbeing at the center.

Dr. Aaron Hartman shares his inspiring journey from a conventional physician to a pioneer in personalized, holistic medicine. He discusses his daughter's remarkable recovery, medical blind spots, the importance of nuance in science, and how patients can advocate for themselves in a complex healthcare system. Through his experiences, Dr. Hartman emphasizes the need for a more integrative approach to healthcare that considers the whole person, not just symptoms. His story highlights the transformative power of patient-centered care and the potential for innovation in medical practices.Product Discount Codes + LinksFroya Organics: Website (Link gives 10% off)MitaCell: WebsiteVio2: Website (Use code LEIGHANN for 10% off)Guest InfoDr. Aaron Hartman - WebsiteDr. Aaron Hartman - InstagramRelated EpisodesPodcast Ep. 228: Dr. Lori Bouchard - The Missing Pieces in Cancer Care,Metabolism, Trauma, and Whole-Person HealingPodcast Ep. 204: Natalie Samson - Exploring Integrative Genetic Counseling as a Transformative Healthcare ApproachWork w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

Send us Fan MailA cancer diagnosis doesn't have to feel like a death sentence. The science is advancing faster than most people realize, and what patients know about their own diagnosis can change everything.Dr. Sanjay Juneja, TheOncDoc joins host John Driscoll to discuss why cancer is increasingly a manageable disease, how patient empowerment and early detection are shifting outcomes, and what everyone can do right now to reduce their cancer risk.

The promise of ARPA‑H isn't just speed, but intention, building ambitious research programs around patient impact rather than hype. One of its newest efforts aims to make cancer treatment simpler, more accessible, and easier to deploy. Here to explain the vision behind “1 Cure,” is the Program Manager Dr. Wilfred Ngwa.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings.” The study—led by corresponding author Pragnesh Parmar, along with Gunvanti Rathod from AIIMS Bibinagar, Telangana, India—brings together evidence from peer-reviewed studies, global health reports, and case examples from regions such as Gaza, Sudan, and Ukraine to examine the structural, ethical, and policy barriers limiting access to cancer care in humanitarian settings. Their findings show that oncology services are often excluded from emergency health priorities, resulting in delayed diagnosis, treatment interruptions, and reduced access to palliative care. The review further highlights that disrupted infrastructure, legal constraints, and fragmented policies disproportionately impact vulnerable populations—including women, children, and the elderly—who often present with advanced disease stages due to delays in care. “Addressing cancer in humanitarian contexts is not merely a technical challenge but a moral imperative.” The authors conclude that integrating oncology into humanitarian response frameworks is essential to ensure equitable access to care and improve outcomes for displaced populations. They emphasize the need for coordinated global strategies, including cross-border care models, tele-oncology, and policy reform, to address this critical gap in global health systems. DOI - https://doi.org/10.18632/oncotarget.28856 Correspondence to - Pragnesh Parmar - drprag@gmail.com; (ORCID: orcid.org/0000-0002-8402-8435) Abstract video - https://www.youtube.com/watch?v=zXlhIBZyJ6Q Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28856 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, cancer care, humanitarian crisis, tele-oncology, global health policy, oncology triage To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this episode, we sit down with Rick Hill, a Clinic Revenue Strategist for Richardson Nutritional Center, author, and expert in alternative health. With over 28 years of experience in sales leadership and a strong focus on integrative nutrition, Rick has dedicated much of his life to exploring innovative, complementary approaches to wellness, especially for those facing serious health challenges. As the co-inventor of the successful AirSource air purification system, which generated $50 million in sales in its first year with Shaklee Corporation, Rick has combined his entrepreneurial spirit with a deep passion for health education. He's also the author of Too Young to Die: Dramatic Use of Laetrile to Conquer Terminal Cancer and The Cancer Conundrum: Stop Dying—Start Living, where he delves into the power of nutrition, enzymes, and alternative therapies in overcoming cancer. In this conversation, we discuss: ·       Rick's personal health journey and how it shapes his views on cancer care. ·       The growing interest in integrative nutrition and alternative health approaches for cancer patients. ·       The role of enzymes, nutrition, and lifestyle changes in achieving better health outcomes. ·       The importance of navigating controversial health topics with knowledge and responsibility. If you're interested in exploring alternative medicine and understanding how personal experiences influence our beliefs about health and wellness, this episode is for you. Follow Rick's work and discover more at https://www.owwc.org/b17works. Episode also available on Apple Podcasts: https://apple.co/38oMlMr  Keep up with Rick Hill socials here: Instagram: https://www.instagram.com/rbarnwellhill/ 

Dr. Thomas Bakman of Helixona integrative medical clinic shares his journey from a farming background in Fresno, California, to becoming a prominent figure in the field of neurology and integrative healthcare. Dr. Bakman delves into the concept of complex chronic illness, explaining how it differs from general chronic illness. He highlights the need to look beyond surface-level symptoms to uncover the root causes of health issues, which often involve a combination of genetic, environmental, and lifestyle factors. The conversation also touches on the hidden neurological factors that impact recovery, including the significance of the nervous system in overall health, the impact of trauma, and the necessity of addressing emotional and psychological aspects of healing. Dr. Bakman shares that Helixona advocates for a holistic approach that combines functional methodology with integrative therapies, ultimately aiming to empower patients to take charge of their health journeys.Product Discount Codes + LinksJuna: Website (Discount Code: LEIGHANN)Broc Shot: Website (Discount Code: LEIGHANNLINDSEY)Hoolest: Website (Discount Code: THEACCRESCENT10)Guest InfoHelixona - WebsiteHelixona - InstagramRelated EpisodesPodcast Ep. 228: Dr. Lori Bouchard - The Missing Pieces in Cancer Care,Metabolism, Trauma, and Whole-Person HealingPodcast Ep. 204: Natalie Samson - Exploring Integrative Genetic Counseling as a Transformative Healthcare ApproachWork w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

GLENN STURM is a 17-year survivor whose journey began the moment a doctor said "incurable cancer," and for the past 16 years, he's kept going with continuous chemotherapy. He's a four-time bestselling author, decorated military officer with over three decades of service, and earned honors from University of Florida Law. These credentials might impress on paper, but it's Glenn's ability to connect with people in crisis that makes him compelling. As someone who's had everything he thought defined him taken away, and then written the roadmap for rebuilding, it's not just survival Glenn shares. He's lived the terror of a diagnosis, the brutality of treatment, and found a way to cultivate hope and practical resilience every day. From what shifts in the mind the moment you hear "cancer" to advice for those newly diagnosed, Glenn brings real tools and unfiltered compassion your listeners will find valuable. Glenn's blend of military perspective, legal rigor, and raw life experience could bring your audience something rare: honest conversation about redefining ourselves when life explodes, delivered by someone who's still living the reality. www.glennsturm.com  

In this episode, Rick Peng, Digital Ventures Lead in Memorial Sloan Kettering Cancer Center (MSK) Office of Entrepreneurship & Commercialization & Natalia Summerville, PhD, Director of Decision Intelligence at Memorial Sloan Kettering Cancer Center, discuss how MSK is advancing AI across clinical care and research while building a robust governance model. They share insights on balancing innovation with safety, ensuring accountability, and driving real impact through thoughtful AI deployment and monitoring.

In this special sponsored episode from Eli Lilly and Company, I am joined by Dr. Lee James, senior vice president of oncology medical affairs at Lilly, to discuss the importance of lung cancer screening, early detection, and advances in biomarker testing. We explore how low-dose CT screening can reduce mortality, yet remains underused, and why comprehensive genomic profiling is essential to understanding the molecular drivers of non-small cell lung cancer and guiding targeted treatment decisions. Tune in to learn how expanding access to screening and precision medicine is helping create new hope for people affected by lung cancer. VISIT SPONSOR → https://www.lilly.com/conditions/cancer/lung-cancer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended